Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2009 1
2012 1
2013 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
Dieplinger H, Ankerst DP, Burges A, Lenhard M, Lingenhel A, Fineder L, Buchner H, Stieber P. Dieplinger H, et al. Among authors: fineder l. Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1127-33. doi: 10.1158/1055-9965.EPI-08-0653. Epub 2009 Mar 31. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19336561
Renal handling of human apolipoprotein(a) and its fragments in the rat.
Reblin T, Donarski N, Fineder L, Bräsen JH, Dieplinger H, Thaiss F, Stahl RA, Beisiegel U, Wolf G. Reblin T, et al. Among authors: fineder l. Am J Kidney Dis. 2001 Sep;38(3):619-30. doi: 10.1053/ajkd.2001.26889. Am J Kidney Dis. 2001. PMID: 11532696
Plasma concentrations of the vitamin E-binding protein afamin are associated with overall and progression-free survival and platinum sensitivity in serous ovarian cancer--a study by the OVCAD consortium.
Melmer A, Fineder L, Lamina C, Kollerits B, Dieplinger B, Braicu I, Sehouli J, Cadron I, Vergote I, Mahner S, Zeimet AG, Castillo-Tong DC, Ebenbichler CF, Zeillinger R, Dieplinger H. Melmer A, et al. Among authors: fineder l. Gynecol Oncol. 2013 Jan;128(1):38-43. doi: 10.1016/j.ygyno.2012.09.032. Epub 2012 Oct 9. Gynecol Oncol. 2013. PMID: 23063758 Clinical Trial.